|
시장보고서
상품코드
2021156
의약품 첨가제 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 범위 - 유형, 임상 적응증, 기능, 용도, 최종사용자 및 지역별Pharmaceutical Excipients Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Clinical Indication, Functionality, Application, End User, and Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
의약품 첨가제 시장 규모는 2025년 100억 3,000만 달러에서 2034년까지 176억 달러로 확대할 것으로 예상되고 있으며, 2026-2034년에 CAGR 6.5%를 기록할 것으로 전망되고 있습니다. 제네릭 의약품 및 첨단 제제에 대한 수요 급증, 신규 첨가제 연구개발 활성화, 바이오의약품 및 바이오시밀러의 성장은 의약품 첨가제 시장 규모 확대에 기여하는 주목할 만한 요인입니다. 또한 다기능 첨가제 및 나노 기술을 이용한 첨가제의 발전과 첨가제 혁신에 AI 및 3D 프린팅의 통합은 가까운 장래에 의약품 첨가제 시장에 새로운 동향을 가져올 것으로 예상됩니다.
현재 의약품 첨가제 시장은 AI와 3D 프린팅 기술의 통합으로 혜택을 받고 있습니다. 이러한 솔루션을 통해 과학자들은 개별화된 제형 설계 및 제조 방법을 개발할 수 있기 때문입니다. AI 알고리즘은 기계 학습을 통해 방대한 첨가제와 유효성분(API)의 상호작용 데이터베이스를 분석하여 최적의 재료 조합을 찾아내는 데 도움을 줍니다. 이를 통해 조사 작업을 가속화하는 동시에 실험실 테스트의 필요성을 줄일 수 있습니다. AI 모델은 예측 능력을 활용하여 첨가제의 용출 프로파일을 생성합니다. 이는 위장 장애를 치료하는 양성자 펌프 억제제의 코팅제로서 다양한 pH 수준에서 어떻게 작용하는지를 보여줍니다.
AI를 보완하는 3D 프린팅 기술은 부형제 매트릭스의 층별 제조를 가능하게 하여 첨가제의 공간적 분포를 정밀하게 제어하여 개별화된 블렌드를 생성할 수 있습니다. 바인더젯 방식의 3D 프린팅 기술과 만니톨 분말을 배합한 폴리비닐피롤리돈(PVP) 부형제를 결합하여 폴리필(방출 속도가 다른 다약제 복합정)을 제조하여 고령 환자가 고혈압과 고지혈증을 동시에 치료하는 데 사용되고 있습니다. AI 제어 3D 프린팅 기술은 바이오의약품용 알긴산 부형제로 다공성 스캐폴드를 제조하고, 만성 상처의 재생치료에서 혈관신생을 촉진하는 조직공학적인 전달 시스템을 구축합니다. 이 시스템은 첨단 기술을 활용하여 복잡한 전달 시스템을 구축하고 있으며, 피부를 통한 인슐린 전달을 위해 젤라틴계 부형제를 포함한 AI 기반 마이크로니들 패치를 사용하여 당뇨병의 혈당 조절을 개선합니다. 이 두 기술의 결합으로 병원은 주문형 의료 제품을 생산할 수 있습니다. 종양학 등 만성질환에서 AI는 화학요법제를 점진적으로 방출하는 3D 프린팅 임플란트 첨가제 간의 시너지 효과를 예측하고 독성을 최소화함으로써 의약품 첨가제 시장의 중요한 동향으로 부상하고 있습니다.
최종사용자별 인사이트
최종사용자별로 의약품 첨가제 시장은 제약 산업, 바이오 제약 산업, 동물용 의약품 및 기타 최종사용자로 분류됩니다. 2025년에는 제약 산업 부문이 의약품 첨가제 시장에서 가장 큰 점유율을 차지했습니다. 이 부문에서 첨가제는 정제 타정, 캡슐 충전, 과립화, 경구, 외용, 주사제, 서방형 제제용 액상 현탁액 등 주요 의약품 제조 공정을 지원하기 위해 결합제, 충전제, 붕괴제, 윤활유, 피막제, 방부제로서 널리 사용되고 있습니다. 이 부문은 제네릭 의약품 시장의 성장을 촉진하는 특허 만료의 지속적인 증가, 장기적인 약물 치료가 필요한 생활습관병의 높은 유병률로 인한 전 세계 인구의 만성질환 유병률 증가, 다기능의 새로운 첨가제 사용이 필요한 약물전달 시스템의 혁신에 대한 수요 증가로 인해 성장할 것으로 예상됩니다. 에 대한 수요 증가로 인해 성장이 예상됩니다. 품질 설계(QbD) 개념에 대한 관심 증가, 환자 중심의 제제 개발, 의약품의 안전성과 유효성에 대한 엄격한 약전 요건도 첨가제 시장의 성장을 촉진하고 있습니다. 또한 개발도상국의 성장 시장에서 의약품에 대한 수요가 증가함에 따라 첨가제 시장의 이 부문의 높은 성장률을 유지하여 의약품 첨가제 시장의 성장을 촉진하고 있습니다.
목차
제1장 개요
제2장 의약품 첨가제 시장 구도
제3장 경쟁 구도
제4장 의약품 첨가제 시장 - 주요 시장 역학
제5장 의약품 첨가제 시장 - 세계 시장 분석
제6장 의약품 첨가제 시장의 매출 분석 - 유형별
제7장 의약품 첨가제 시장의 매출 분석 - 임상 적응증
제8장 의약품 첨가제 시장의 매출 분석 - 기능별
제9장 의약품 첨가제 시장의 매출 분석 - 용도별
제10장 의약품 첨가제 시장의 매출 분석 - 최종사용자별
제11장 의약품 첨가제 시장 - 지역 분석
제12장 의약품 첨가제 시장의 업계 상황
제13장 의약품 첨가제 시장 - 주요 기업 개요
제14장 부록
KSA 26.05.12The pharmaceutical excipients market size is expected to grow from US$ 10.03 billion in 2025 to US$ 17.60 billion by 2034; it is projected to register a CAGR of 6.5% during 2026-2034. The surging demand for generic medications and advanced formulations, increasing research and development efforts in novel excipients, and growing biopharmaceuticals and biosimilars are noteworthy factors contributing to the expansion of the pharmaceutical excipients market size. Additionally, growing advancements in multifunctional and nanotechnology excipients, and integration of AI and 3D printing in excipient innovation are projected to bring new pharmaceutical excipients market trends in the near future.
The pharmaceutical excipients market now benefits from AI integration with 3D printing technology because these solutions enable scientists to create personalized formulation designs and production methods. AI algorithms use machine learning to study extensive excipient-API interaction databases, which helps them determine the best material combinations and speeds up research work while decreasing laboratory testing needs. AI models use their predictive capabilities to create dissolution profiles of excipients, which show how they will perform at different pH levels to create coatings for proton pump inhibitors that treat gastrointestinal disorders.
Complementing AI, 3D printing technologies enable the layer-by-layer fabrication of excipient matrices, creating personalized blends with precise spatial distributions of additives. The combination of binder jetting 3D printing technology and mannitol-powdered polyvinylpyrrolidone excipients creates polypills (multi-drug tablets with varying release rates), which elderly patients use to treat simultaneous hypertension and hyperlipidemia. AI-controlled 3D printing technology produces porous scaffolds from alginate-based excipients for biologics, which create tissue-engineered delivery systems that enhance vascularization in regenerative treatments for chronic wounds. The system uses advanced technologies to create complex delivery systems that use AI-based microneedle patches that contain gelatin-based excipients for insulin delivery through the skin, which provide better diabetes glucose level control. The combination of these two technologies enables hospitals to produce medical products on demand. In chronic conditions, such as oncology, AI predicts excipient synergies for 3D-printed implants that release chemotherapeutics gradually, minimizing toxicity, thereby emerging as a significant trend in the pharmaceutical excipients market.
End User-Based Insights
Based on end user, the pharmaceutical excipients market is segmented into pharma industries, biopharma industries, animal health, and other end user. The pharma industries segment held the largest pharmaceutical excipients market share in 2025. In the market, this segment makes extensive use of excipients as binders, fillers, disintegrants, lubricants, coatings, and preservatives in supporting key pharmaceutical manufacturing operations such as tablet compression, capsule filling, granulation, and liquid suspensions for oral, topical, injectable, and controlled-release dosage forms. This segment is likely to grow due to the continuous wave of patent expirations fueling the growth of generic drug markets, the rising incidence rate of chronic diseases in the global population due to the high prevalence rate of lifestyle disorders that necessitate long-term drug therapies, and the increasing need for drug delivery system innovations that necessitate the use of multifunctional and novel excipients. The increasing focus on quality by design concepts, patient-oriented drug formulations, and stringent pharmacopeial requirements for drug safety and efficacy also fuels the growth of this segment in the excipients market. Additionally, the increasing need for drug availability in the growing markets in the developing world continues to maintain a high growth rate in this segment of the excipients market, thereby fueling the pharmaceutical excipients market growth.
The World Health Organization, Pan American Health Organization, and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the pharmaceutical excipients market report.
Table Of Contents
1. Executive Summary
- 1.1 Analyst Market Outlook
- 1.2 Market Attractiveness
2. Pharmaceutical Excipients Market Landscape
- 2.1 Overview
- 2.2 Value Chain Analysis
- 2.2.1 Raw Material Suppliers / Components
- 2.2.2 Manufacturers Process / Technology
- 2.2.3 Distribution Landscape
- 2.2.4 End-User
- 2.2.5 Level of Integration
- 2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
- 2.4 PEST Analysis
- 2.5 Impact of Artificial Intelligence (AI)
- 2.6 Product or Technology Roadmap
- 2.7 Sustainability and ESG Trends
- 2.8 Regulatory Framework
- 2.9 Average Selling Prices of Key Products by Key Geographies
- 2.10 Pricing Trend Analysis
- 2.11 Regional Pricing Benchmarking
- 2.12 Raw Material Cost Impact Analysis
3. Competitive Landscape
- 3.1 Company Benchmarking by Key Players
- 3.2 Market Share Analysis, 2025 - By Key Players
- 3.3 Market Concentration
4. Pharmaceutical Excipients Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Surging Demand for Generic Medications and Advanced Formulations
- 4.1.2 Increasing Research and Development Efforts in Novel Excipients
- 4.1.3 Growing Biopharmaceuticals and Biosimilars
- 4.2 Market Restraints
- 4.2.1 Stringent and Complex Regulatory Frameworks
- 4.2.2 High Costs of Development and Manufacturing
- 4.2.3 Ongoing Safety and Quality Concerns
- 4.3 Market Opportunities
- 4.3.1 Expansion in Emerging Economies
- 4.3.2 Shift Toward Patient-Centric and Continuous Manufacturing
- 4.3.3 Preference for Plant-Derived and Sustainable Excipients
- 4.4 Future Trends
- 4.4.1 Growing Advancements in Multifunctional and Nanotechnology Excipients
- 4.4.2 Rising Adoption of Biologics and Novel Delivery Systems
- 4.4.3 Integration of AI and 3D Printing in Excipient Innovation
- 4.5 Impact of Drivers and Restraints
5. Pharmaceutical Excipients Market - Global Market Analysis
- 5.1 Pharmaceutical Excipients Market Revenue (US$ Million), 2021-2034
- 5.2 Pharmaceutical Excipients Market Forecast and Analysis
6. Pharmaceutical Excipients Market Revenue Analysis -Type
- 6.1 Pharmaceutical Excipients Market Forecasts and Analysis by Type
- 6.1.1 Bioresorbable Polymers and Lipids and Liposome Based Formulation
- 6.1.1.1 Overview
- 6.1.1.2 Bioresorbable Polymers and Lipids and Liposome Based Formulation: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 6.1.2 Oleochemicals
- 6.1.2.1 Overview
- 6.1.2.2 Oleochemicals: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 6.1.3 Sugars
- 6.1.3.1 Overview
- 6.1.3.2 Sugars: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 6.1.4 Cellulose
- 6.1.4.1 Overview
- 6.1.4.2 Cellulose: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 6.1.5 Starches
- 6.1.5.1 Overview
- 6.1.5.2 Starches: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 6.1.6 Petrochemicals
- 6.1.6.1 Overview
- 6.1.6.2 Petrochemicals: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 6.1.7 Plant Proteins Polyols and Cyclodextrins
- 6.1.7.1 Overview
- 6.1.7.2 Plant Proteins Polyols and Cyclodextrins: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 6.1.8 Inorganic Chemicals
- 6.1.8.1 Overview
- 6.1.8.2 Inorganic Chemicals: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 6.1.9 Others
- 6.1.9.1 Overview
- 6.1.9.2 Others: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 6.1.1 Bioresorbable Polymers and Lipids and Liposome Based Formulation
7. Pharmaceutical Excipients Market Revenue Analysis -Clinical Indication
- 7.1 Pharmaceutical Excipients Market Forecasts and Analysis by Clinical Indication
- 7.1.1 Cancer
- 7.1.1.1 Overview
- 7.1.1.2 Cancer: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 7.1.2 Metabolic
- 7.1.2.1 Overview
- 7.1.2.2 Metabolic: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 7.1.3 Infectious Disease
- 7.1.3.1 Overview
- 7.1.3.2 Infectious Disease: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 7.1.4 Dental
- 7.1.4.1 Overview
- 7.1.4.2 Dental: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 7.1.5 Ophthalmic
- 7.1.5.1 Overview
- 7.1.5.2 Ophthalmic: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 7.1.6 Cardiovascular
- 7.1.6.1 Overview
- 7.1.6.2 Cardiovascular: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 7.1.7 Other Clinical Indications
- 7.1.7.1 Overview
- 7.1.7.2 Other Clinical Indications: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 7.1.1 Cancer
8. Pharmaceutical Excipients Market Revenue Analysis -Functionality
- 8.1 Pharmaceutical Excipients Market Forecasts and Analysis by Functionality
- 8.1.1 Coloring Agents and Coating Agents
- 8.1.1.1 Overview
- 8.1.1.2 Coloring Agents and Coating Agents: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.2 Sweetner and Flavoring Agents
- 8.1.2.1 Overview
- 8.1.2.2 Sweetner and Flavoring Agents: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.3 Suspending and Viscosity Agents
- 8.1.3.1 Overview
- 8.1.3.2 Suspending and Viscosity Agents: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.4 Preservative and Controlled Release
- 8.1.4.1 Overview
- 8.1.4.2 Preservative and Controlled Release: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.5 Antioxidant and Oil
- 8.1.5.1 Overview
- 8.1.5.2 Antioxidant and Oil: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.6 Tablet Filler and Diluent
- 8.1.6.1 Overview
- 8.1.6.2 Tablet Filler and Diluent: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.7 Binder and Compression and Granulating Agents
- 8.1.7.1 Overview
- 8.1.7.2 Binder and Compression and Granulating Agents: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.8 Emulsifiers
- 8.1.8.1 Overview
- 8.1.8.2 Emulsifiers: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.9 Surfactants
- 8.1.9.1 Overview
- 8.1.9.2 Surfactants: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.10 Others
- 8.1.10.1 Overview
- 8.1.10.2 Others: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 8.1.1 Coloring Agents and Coating Agents
9. Pharmaceutical Excipients Market Revenue Analysis -Application
- 9.1 Pharmaceutical Excipients Market Forecasts and Analysis by Application
- 9.1.1 Oral
- 9.1.1.1 Overview
- 9.1.1.2 Oral: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 9.1.2 Injectable
- 9.1.2.1 Overview
- 9.1.2.2 Injectable: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 9.1.3 Topical
- 9.1.3.1 Overview
- 9.1.3.2 Topical: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 9.1.4 Others
- 9.1.4.1 Overview
- 9.1.4.2 Others: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 9.1.1 Oral
10. Pharmaceutical Excipients Market Revenue Analysis -End User
- 10.1 Pharmaceutical Excipients Market Forecasts and Analysis by End User
- 10.1.1 Pharma Industries
- 10.1.1.1 Overview
- 10.1.1.2 Pharma Industries: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 10.1.2 Biopharma Industries
- 10.1.2.1 Overview
- 10.1.2.2 Biopharma Industries: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 10.1.3 Animal Health
- 10.1.3.1 Overview
- 10.1.3.2 Animal Health: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 10.1.4 Other End User
- 10.1.4.1 Overview
- 10.1.4.2 Other End User: Pharmaceutical Excipients Market -Revenue, 2021-2034 (US$ Million)
- 10.1.1 Pharma Industries
11. Pharmaceutical Excipients Market - Geographical Analysis
- 11.1 North America
- 11.1.1 North America Pharmaceutical Excipients Market Overview
- 11.1.2 North America: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.1.3 North America: Pharmaceutical Excipients Market- By Segmentation
- 11.1.3.1 Type
- 11.1.3.2 Oleochemicals For Type
- 11.1.3.3 Sugars For Type
- 11.1.3.4 Cellulose For Type
- 11.1.3.5 Starches For Type
- 11.1.3.6 Petrochemicals For Type
- 11.1.3.7 Inorganic Chemicals For Type
- 11.1.3.8 Clinical Indication
- 11.1.3.9 Functionality
- 11.1.3.10 Surfactants For Functionality
- 11.1.3.11 Application
- 11.1.3.12 Oral For Application
- 11.1.3.13 Capsule For Oral
- 11.1.3.14 End User
- 11.1.4 North America: Pharmaceutical Excipients Market Breakdown by Countries
- 11.1.4.1 United States Market
- 11.1.4.1.1 United States: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.1.4.1.2 United States: Pharmaceutical Excipients Market- By Segmentation
- 11.1.4.1.2.1 Type
- 11.1.4.1.2.2 Oleochemicals For Type
- 11.1.4.1.2.3 Sugars For Type
- 11.1.4.1.2.4 Cellulose For Type
- 11.1.4.1.2.5 Starches For Type
- 11.1.4.1.2.6 Petrochemicals For Type
- 11.1.4.1.2.7 Inorganic Chemicals For Type
- 11.1.4.1.2.8 Clinical Indication
- 11.1.4.1.2.9 Functionality
- 11.1.4.1.2.10 Surfactants For Functionality
- 11.1.4.1.2.11 Application
- 11.1.4.1.2.12 Oral For Application
- 11.1.4.1.2.13 Capsule For Oral
- 11.1.4.1.2.14 End User
- 11.1.4.2 Canada Market
- 11.1.4.2.1 Canada: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.1.4.2.2 Canada: Pharmaceutical Excipients Market- By Segmentation
- 11.1.4.2.2.1 Type
- 11.1.4.2.2.2 Oleochemicals For Type
- 11.1.4.2.2.3 Sugars For Type
- 11.1.4.2.2.4 Cellulose For Type
- 11.1.4.2.2.5 Starches For Type
- 11.1.4.2.2.6 Petrochemicals For Type
- 11.1.4.2.2.7 Inorganic Chemicals For Type
- 11.1.4.2.2.8 Clinical Indication
- 11.1.4.2.2.9 Functionality
- 11.1.4.2.2.10 Surfactants For Functionality
- 11.1.4.2.2.11 Application
- 11.1.4.2.2.12 Oral For Application
- 11.1.4.2.2.13 Capsule For Oral
- 11.1.4.2.2.14 End User
- 11.1.4.3 Mexico Market
- 11.1.4.3.1 Mexico: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.1.4.3.2 Mexico: Pharmaceutical Excipients Market- By Segmentation
- 11.1.4.3.2.1 Type
- 11.1.4.3.2.2 Oleochemicals For Type
- 11.1.4.3.2.3 Sugars For Type
- 11.1.4.3.2.4 Cellulose For Type
- 11.1.4.3.2.5 Starches For Type
- 11.1.4.3.2.6 Petrochemicals For Type
- 11.1.4.3.2.7 Inorganic Chemicals For Type
- 11.1.4.3.2.8 Clinical Indication
- 11.1.4.3.2.9 Functionality
- 11.1.4.3.2.10 Surfactants For Functionality
- 11.1.4.3.2.11 Application
- 11.1.4.3.2.12 Oral For Application
- 11.1.4.3.2.13 Capsule For Oral
- 11.1.4.3.2.14 End User
- 11.1.4.1 United States Market
- 11.2 Europe
- 11.2.1 Europe Pharmaceutical Excipients Market Overview
- 11.2.2 Europe: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.3 Europe: Pharmaceutical Excipients Market- By Segmentation
- 11.2.3.1 Type
- 11.2.3.2 Oleochemicals For Type
- 11.2.3.3 Sugars For Type
- 11.2.3.4 Cellulose For Type
- 11.2.3.5 Starches For Type
- 11.2.3.6 Petrochemicals For Type
- 11.2.3.7 Inorganic Chemicals For Type
- 11.2.3.8 Clinical Indication
- 11.2.3.9 Functionality
- 11.2.3.10 Surfactants For Functionality
- 11.2.3.11 Application
- 11.2.3.12 Oral For Application
- 11.2.3.13 Capsule For Oral
- 11.2.3.14 End User
- 11.2.4 Europe: Pharmaceutical Excipients Market Breakdown by Countries
- 11.2.4.1 Germany Market
- 11.2.4.1.1 Germany: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.1.2 Germany: Pharmaceutical Excipients Market- By Segmentation
- 11.2.4.1.2.1 Type
- 11.2.4.1.2.2 Oleochemicals For Type
- 11.2.4.1.2.3 Sugars For Type
- 11.2.4.1.2.4 Cellulose For Type
- 11.2.4.1.2.5 Starches For Type
- 11.2.4.1.2.6 Petrochemicals For Type
- 11.2.4.1.2.7 Inorganic Chemicals For Type
- 11.2.4.1.2.8 Clinical Indication
- 11.2.4.1.2.9 Functionality
- 11.2.4.1.2.10 Surfactants For Functionality
- 11.2.4.1.2.11 Application
- 11.2.4.1.2.12 Oral For Application
- 11.2.4.1.2.13 Capsule For Oral
- 11.2.4.1.2.14 End User
- 11.2.4.2 United Kingdom Market
- 11.2.4.2.1 United Kingdom: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.2.2 United Kingdom: Pharmaceutical Excipients Market- By Segmentation
- 11.2.4.2.2.1 Type
- 11.2.4.2.2.2 Oleochemicals For Type
- 11.2.4.2.2.3 Sugars For Type
- 11.2.4.2.2.4 Cellulose For Type
- 11.2.4.2.2.5 Starches For Type
- 11.2.4.2.2.6 Petrochemicals For Type
- 11.2.4.2.2.7 Inorganic Chemicals For Type
- 11.2.4.2.2.8 Clinical Indication
- 11.2.4.2.2.9 Functionality
- 11.2.4.2.2.10 Surfactants For Functionality
- 11.2.4.2.2.11 Application
- 11.2.4.2.2.12 Oral For Application
- 11.2.4.2.2.13 Capsule For Oral
- 11.2.4.2.2.14 End User
- 11.2.4.3 France Market
- 11.2.4.3.1 France: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.3.2 France: Pharmaceutical Excipients Market- By Segmentation
- 11.2.4.3.2.1 Type
- 11.2.4.3.2.2 Oleochemicals For Type
- 11.2.4.3.2.3 Sugars For Type
- 11.2.4.3.2.4 Cellulose For Type
- 11.2.4.3.2.5 Starches For Type
- 11.2.4.3.2.6 Petrochemicals For Type
- 11.2.4.3.2.7 Inorganic Chemicals For Type
- 11.2.4.3.2.8 Clinical Indication
- 11.2.4.3.2.9 Functionality
- 11.2.4.3.2.10 Surfactants For Functionality
- 11.2.4.3.2.11 Application
- 11.2.4.3.2.12 Oral For Application
- 11.2.4.3.2.13 Capsule For Oral
- 11.2.4.3.2.14 End User
- 11.2.4.4 Italy Market
- 11.2.4.4.1 Italy: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.4.2 Italy: Pharmaceutical Excipients Market- By Segmentation
- 11.2.4.4.2.1 Type
- 11.2.4.4.2.2 Oleochemicals For Type
- 11.2.4.4.2.3 Sugars For Type
- 11.2.4.4.2.4 Cellulose For Type
- 11.2.4.4.2.5 Starches For Type
- 11.2.4.4.2.6 Petrochemicals For Type
- 11.2.4.4.2.7 Inorganic Chemicals For Type
- 11.2.4.4.2.8 Clinical Indication
- 11.2.4.4.2.9 Functionality
- 11.2.4.4.2.10 Surfactants For Functionality
- 11.2.4.4.2.11 Application
- 11.2.4.4.2.12 Oral For Application
- 11.2.4.4.2.13 Capsule For Oral
- 11.2.4.4.2.14 End User
- 11.2.4.5 Spain Market
- 11.2.4.5.1 Spain: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.5.2 Spain: Pharmaceutical Excipients Market- By Segmentation
- 11.2.4.5.2.1 Type
- 11.2.4.5.2.2 Oleochemicals For Type
- 11.2.4.5.2.3 Sugars For Type
- 11.2.4.5.2.4 Cellulose For Type
- 11.2.4.5.2.5 Starches For Type
- 11.2.4.5.2.6 Petrochemicals For Type
- 11.2.4.5.2.7 Inorganic Chemicals For Type
- 11.2.4.5.2.8 Clinical Indication
- 11.2.4.5.2.9 Functionality
- 11.2.4.5.2.10 Surfactants For Functionality
- 11.2.4.5.2.11 Application
- 11.2.4.5.2.12 Oral For Application
- 11.2.4.5.2.13 Capsule For Oral
- 11.2.4.5.2.14 End User
- 11.2.4.6 Rest of Europe Market
- 11.2.4.6.1 Rest of Europe: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.6.2 Rest of Europe: Pharmaceutical Excipients Market- By Segmentation
- 11.2.4.6.2.1 Type
- 11.2.4.6.2.2 Oleochemicals For Type
- 11.2.4.6.2.3 Sugars For Type
- 11.2.4.6.2.4 Cellulose For Type
- 11.2.4.6.2.5 Starches For Type
- 11.2.4.6.2.6 Petrochemicals For Type
- 11.2.4.6.2.7 Inorganic Chemicals For Type
- 11.2.4.6.2.8 Clinical Indication
- 11.2.4.6.2.9 Functionality
- 11.2.4.6.2.10 Surfactants For Functionality
- 11.2.4.6.2.11 Application
- 11.2.4.6.2.12 Oral For Application
- 11.2.4.6.2.13 Capsule For Oral
- 11.2.4.6.2.14 End User
- 11.2.4.1 Germany Market
- 11.3 Asia Pacific
- 11.3.1 Asia Pacific Pharmaceutical Excipients Market Overview
- 11.3.2 Asia Pacific: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.3 Asia Pacific: Pharmaceutical Excipients Market- By Segmentation
- 11.3.3.1 Type
- 11.3.3.2 Oleochemicals For Type
- 11.3.3.3 Sugars For Type
- 11.3.3.4 Cellulose For Type
- 11.3.3.5 Starches For Type
- 11.3.3.6 Petrochemicals For Type
- 11.3.3.7 Inorganic Chemicals For Type
- 11.3.3.8 Clinical Indication
- 11.3.3.9 Functionality
- 11.3.3.10 Surfactants For Functionality
- 11.3.3.11 Application
- 11.3.3.12 Oral For Application
- 11.3.3.13 Capsule For Oral
- 11.3.3.14 End User
- 11.3.4 Asia Pacific: Pharmaceutical Excipients Market Breakdown by Countries
- 11.3.4.1 China Market
- 11.3.4.1.1 China: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.1.2 China: Pharmaceutical Excipients Market- By Segmentation
- 11.3.4.1.2.1 Type
- 11.3.4.1.2.2 Oleochemicals For Type
- 11.3.4.1.2.3 Sugars For Type
- 11.3.4.1.2.4 Cellulose For Type
- 11.3.4.1.2.5 Starches For Type
- 11.3.4.1.2.6 Petrochemicals For Type
- 11.3.4.1.2.7 Inorganic Chemicals For Type
- 11.3.4.1.2.8 Clinical Indication
- 11.3.4.1.2.9 Functionality
- 11.3.4.1.2.10 Surfactants For Functionality
- 11.3.4.1.2.11 Application
- 11.3.4.1.2.12 Oral For Application
- 11.3.4.1.2.13 Capsule For Oral
- 11.3.4.1.2.14 End User
- 11.3.4.2 Japan Market
- 11.3.4.2.1 Japan: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.2.2 Japan: Pharmaceutical Excipients Market- By Segmentation
- 11.3.4.2.2.1 Type
- 11.3.4.2.2.2 Oleochemicals For Type
- 11.3.4.2.2.3 Sugars For Type
- 11.3.4.2.2.4 Cellulose For Type
- 11.3.4.2.2.5 Starches For Type
- 11.3.4.2.2.6 Petrochemicals For Type
- 11.3.4.2.2.7 Inorganic Chemicals For Type
- 11.3.4.2.2.8 Clinical Indication
- 11.3.4.2.2.9 Functionality
- 11.3.4.2.2.10 Surfactants For Functionality
- 11.3.4.2.2.11 Application
- 11.3.4.2.2.12 Oral For Application
- 11.3.4.2.2.13 Capsule For Oral
- 11.3.4.2.2.14 End User
- 11.3.4.3 India Market
- 11.3.4.3.1 India: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.3.2 India: Pharmaceutical Excipients Market- By Segmentation
- 11.3.4.3.2.1 Type
- 11.3.4.3.2.2 Oleochemicals For Type
- 11.3.4.3.2.3 Sugars For Type
- 11.3.4.3.2.4 Cellulose For Type
- 11.3.4.3.2.5 Starches For Type
- 11.3.4.3.2.6 Petrochemicals For Type
- 11.3.4.3.2.7 Inorganic Chemicals For Type
- 11.3.4.3.2.8 Clinical Indication
- 11.3.4.3.2.9 Functionality
- 11.3.4.3.2.10 Surfactants For Functionality
- 11.3.4.3.2.11 Application
- 11.3.4.3.2.12 Oral For Application
- 11.3.4.3.2.13 Capsule For Oral
- 11.3.4.3.2.14 End User
- 11.3.4.4 Australia Market
- 11.3.4.4.1 Australia: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.4.2 Australia: Pharmaceutical Excipients Market- By Segmentation
- 11.3.4.4.2.1 Type
- 11.3.4.4.2.2 Oleochemicals For Type
- 11.3.4.4.2.3 Sugars For Type
- 11.3.4.4.2.4 Cellulose For Type
- 11.3.4.4.2.5 Starches For Type
- 11.3.4.4.2.6 Petrochemicals For Type
- 11.3.4.4.2.7 Inorganic Chemicals For Type
- 11.3.4.4.2.8 Clinical Indication
- 11.3.4.4.2.9 Functionality
- 11.3.4.4.2.10 Surfactants For Functionality
- 11.3.4.4.2.11 Application
- 11.3.4.4.2.12 Oral For Application
- 11.3.4.4.2.13 Capsule For Oral
- 11.3.4.4.2.14 End User
- 11.3.4.5 South Korea Market
- 11.3.4.5.1 South Korea: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.5.2 South Korea: Pharmaceutical Excipients Market- By Segmentation
- 11.3.4.5.2.1 Type
- 11.3.4.5.2.2 Oleochemicals For Type
- 11.3.4.5.2.3 Sugars For Type
- 11.3.4.5.2.4 Cellulose For Type
- 11.3.4.5.2.5 Starches For Type
- 11.3.4.5.2.6 Petrochemicals For Type
- 11.3.4.5.2.7 Inorganic Chemicals For Type
- 11.3.4.5.2.8 Clinical Indication
- 11.3.4.5.2.9 Functionality
- 11.3.4.5.2.10 Surfactants For Functionality
- 11.3.4.5.2.11 Application
- 11.3.4.5.2.12 Oral For Application
- 11.3.4.5.2.13 Capsule For Oral
- 11.3.4.5.2.14 End User
- 11.3.4.6 Rest of APAC Market
- 11.3.4.6.1 Rest of APAC: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.6.2 Rest of APAC: Pharmaceutical Excipients Market- By Segmentation
- 11.3.4.6.2.1 Type
- 11.3.4.6.2.2 Oleochemicals For Type
- 11.3.4.6.2.3 Sugars For Type
- 11.3.4.6.2.4 Cellulose For Type
- 11.3.4.6.2.5 Starches For Type
- 11.3.4.6.2.6 Petrochemicals For Type
- 11.3.4.6.2.7 Inorganic Chemicals For Type
- 11.3.4.6.2.8 Clinical Indication
- 11.3.4.6.2.9 Functionality
- 11.3.4.6.2.10 Surfactants For Functionality
- 11.3.4.6.2.11 Application
- 11.3.4.6.2.12 Oral For Application
- 11.3.4.6.2.13 Capsule For Oral
- 11.3.4.6.2.14 End User
- 11.3.4.1 China Market
- 11.4 Middle East and Africa
- 11.4.1 Middle East and Africa Pharmaceutical Excipients Market Overview
- 11.4.2 Middle East and Africa: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.3 Middle East and Africa: Pharmaceutical Excipients Market- By Segmentation
- 11.4.3.1 Type
- 11.4.3.2 Oleochemicals For Type
- 11.4.3.3 Sugars For Type
- 11.4.3.4 Cellulose For Type
- 11.4.3.5 Starches For Type
- 11.4.3.6 Petrochemicals For Type
- 11.4.3.7 Inorganic Chemicals For Type
- 11.4.3.8 Clinical Indication
- 11.4.3.9 Functionality
- 11.4.3.10 Surfactants For Functionality
- 11.4.3.11 Application
- 11.4.3.12 Oral For Application
- 11.4.3.13 Capsule For Oral
- 11.4.3.14 End User
- 11.4.4 Middle East and Africa: Pharmaceutical Excipients Market Breakdown by Countries
- 11.4.4.1 Saudi Arabia Market
- 11.4.4.1.1 Saudi Arabia: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.4.1.2 Saudi Arabia: Pharmaceutical Excipients Market- By Segmentation
- 11.4.4.1.2.1 Type
- 11.4.4.1.2.2 Oleochemicals For Type
- 11.4.4.1.2.3 Sugars For Type
- 11.4.4.1.2.4 Cellulose For Type
- 11.4.4.1.2.5 Starches For Type
- 11.4.4.1.2.6 Petrochemicals For Type
- 11.4.4.1.2.7 Inorganic Chemicals For Type
- 11.4.4.1.2.8 Clinical Indication
- 11.4.4.1.2.9 Functionality
- 11.4.4.1.2.10 Surfactants For Functionality
- 11.4.4.1.2.11 Application
- 11.4.4.1.2.12 Oral For Application
- 11.4.4.1.2.13 Capsule For Oral
- 11.4.4.1.2.14 End User
- 11.4.4.2 South Africa Market
- 11.4.4.2.1 South Africa: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.4.2.2 South Africa: Pharmaceutical Excipients Market- By Segmentation
- 11.4.4.2.2.1 Type
- 11.4.4.2.2.2 Oleochemicals For Type
- 11.4.4.2.2.3 Sugars For Type
- 11.4.4.2.2.4 Cellulose For Type
- 11.4.4.2.2.5 Starches For Type
- 11.4.4.2.2.6 Petrochemicals For Type
- 11.4.4.2.2.7 Inorganic Chemicals For Type
- 11.4.4.2.2.8 Clinical Indication
- 11.4.4.2.2.9 Functionality
- 11.4.4.2.2.10 Surfactants For Functionality
- 11.4.4.2.2.11 Application
- 11.4.4.2.2.12 Oral For Application
- 11.4.4.2.2.13 Capsule For Oral
- 11.4.4.2.2.14 End User
- 11.4.4.3 United Arab Emirates Market
- 11.4.4.3.1 United Arab Emirates: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.4.3.2 United Arab Emirates: Pharmaceutical Excipients Market- By Segmentation
- 11.4.4.3.2.1 Type
- 11.4.4.3.2.2 Oleochemicals For Type
- 11.4.4.3.2.3 Sugars For Type
- 11.4.4.3.2.4 Cellulose For Type
- 11.4.4.3.2.5 Starches For Type
- 11.4.4.3.2.6 Petrochemicals For Type
- 11.4.4.3.2.7 Inorganic Chemicals For Type
- 11.4.4.3.2.8 Clinical Indication
- 11.4.4.3.2.9 Functionality
- 11.4.4.3.2.10 Surfactants For Functionality
- 11.4.4.3.2.11 Application
- 11.4.4.3.2.12 Oral For Application
- 11.4.4.3.2.13 Capsule For Oral
- 11.4.4.3.2.14 End User
- 11.4.4.4 Rest of Middle East and Africa Market
- 11.4.4.4.1 Rest of Middle East and Africa: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.4.4.2 Rest of Middle East and Africa: Pharmaceutical Excipients Market- By Segmentation
- 11.4.4.4.2.1 Type
- 11.4.4.4.2.2 Oleochemicals For Type
- 11.4.4.4.2.3 Sugars For Type
- 11.4.4.4.2.4 Cellulose For Type
- 11.4.4.4.2.5 Starches For Type
- 11.4.4.4.2.6 Petrochemicals For Type
- 11.4.4.4.2.7 Inorganic Chemicals For Type
- 11.4.4.4.2.8 Clinical Indication
- 11.4.4.4.2.9 Functionality
- 11.4.4.4.2.10 Surfactants For Functionality
- 11.4.4.4.2.11 Application
- 11.4.4.4.2.12 Oral For Application
- 11.4.4.4.2.13 Capsule For Oral
- 11.4.4.4.2.14 End User
- 11.4.4.1 Saudi Arabia Market
- 11.5 South and Central America
- 11.5.1 South and Central America Pharmaceutical Excipients Market Overview
- 11.5.2 South and Central America: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.5.3 South and Central America: Pharmaceutical Excipients Market- By Segmentation
- 11.5.3.1 Type
- 11.5.3.2 Oleochemicals For Type
- 11.5.3.3 Sugars For Type
- 11.5.3.4 Cellulose For Type
- 11.5.3.5 Starches For Type
- 11.5.3.6 Petrochemicals For Type
- 11.5.3.7 Inorganic Chemicals For Type
- 11.5.3.8 Clinical Indication
- 11.5.3.9 Functionality
- 11.5.3.10 Surfactants For Functionality
- 11.5.3.11 Application
- 11.5.3.12 Oral For Application
- 11.5.3.13 Capsule For Oral
- 11.5.3.14 End User
- 11.5.4 South and Central America: Pharmaceutical Excipients Market Breakdown by Countries
- 11.5.4.1 Brazil Market
- 11.5.4.1.1 Brazil: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.5.4.1.2 Brazil: Pharmaceutical Excipients Market- By Segmentation
- 11.5.4.1.2.1 Type
- 11.5.4.1.2.2 Oleochemicals For Type
- 11.5.4.1.2.3 Sugars For Type
- 11.5.4.1.2.4 Cellulose For Type
- 11.5.4.1.2.5 Starches For Type
- 11.5.4.1.2.6 Petrochemicals For Type
- 11.5.4.1.2.7 Inorganic Chemicals For Type
- 11.5.4.1.2.8 Clinical Indication
- 11.5.4.1.2.9 Functionality
- 11.5.4.1.2.10 Surfactants For Functionality
- 11.5.4.1.2.11 Application
- 11.5.4.1.2.12 Oral For Application
- 11.5.4.1.2.13 Capsule For Oral
- 11.5.4.1.2.14 End User
- 11.5.4.2 Argentina Market
- 11.5.4.2.1 Argentina: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.5.4.2.2 Argentina: Pharmaceutical Excipients Market- By Segmentation
- 11.5.4.2.2.1 Type
- 11.5.4.2.2.2 Oleochemicals For Type
- 11.5.4.2.2.3 Sugars For Type
- 11.5.4.2.2.4 Cellulose For Type
- 11.5.4.2.2.5 Starches For Type
- 11.5.4.2.2.6 Petrochemicals For Type
- 11.5.4.2.2.7 Inorganic Chemicals For Type
- 11.5.4.2.2.8 Clinical Indication
- 11.5.4.2.2.9 Functionality
- 11.5.4.2.2.10 Surfactants For Functionality
- 11.5.4.2.2.11 Application
- 11.5.4.2.2.12 Oral For Application
- 11.5.4.2.2.13 Capsule For Oral
- 11.5.4.2.2.14 End User
- 11.5.4.3 Rest of South and Central America Market
- 11.5.4.3.1 Rest of South and Central America: Pharmaceutical Excipients Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.5.4.3.2 Rest of South and Central America: Pharmaceutical Excipients Market- By Segmentation
- 11.5.4.3.2.1 Type
- 11.5.4.3.2.2 Oleochemicals For Type
- 11.5.4.3.2.3 Sugars For Type
- 11.5.4.3.2.4 Cellulose For Type
- 11.5.4.3.2.5 Starches For Type
- 11.5.4.3.2.6 Petrochemicals For Type
- 11.5.4.3.2.7 Inorganic Chemicals For Type
- 11.5.4.3.2.8 Clinical Indication
- 11.5.4.3.2.9 Functionality
- 11.5.4.3.2.10 Surfactants For Functionality
- 11.5.4.3.2.11 Application
- 11.5.4.3.2.12 Oral For Application
- 11.5.4.3.2.13 Capsule For Oral
- 11.5.4.3.2.14 End User
- 11.5.4.1 Brazil Market
12. Pharmaceutical Excipients Market Industry Landscape
13. Pharmaceutical Excipients Market - Key Company Profiles
- 13.1 Roquette Freres SA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 BASF SE
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Evonik Industries AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Archer-Daniels-Midland Co
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 The Lubrizol Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 The Dow Chemical Co
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Ashland Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 JRS PHARMA GmbH & Co KG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Avantor Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 MEGGLE GmbH & Co KG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
- 13.11 Merck KGaA
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
14. Appendix
- 14.1 Glossary
- 14.4 Research Methodology and Approach
- 14.4.1 Secondary Research
- 14.4.2 Primary Research
- 14.4.3 Market Estimation Approach
- 14.4.3.1 Supply Side Analysis
- 14.4.3.2 Demand Side Analysis
- 14.4.4 Research Assumptions and Limitations
- 14.4.5 Currency Conversion
- 14.5 About The Insight Partners
- 14.6 Market Intelligence Cloud
